Speakers

Prof. Nadia Al Mazrouei is an esteemed Emirati pharmacy leader with over 35 years of transformative contributions to clinical pharmacy, healthcare leadership, and global pharmaceutical policy.

In 2025, she was elected Vice President of the International Pharmaceutical Federation (FIP) and awarded the prestigious FIP Fellowship in recognition of her outstanding efforts in advancing pharmacy education, regulation, and practice worldwide.

She currently serves as President of the ISPOR UAE Chapter, Member of the WHO Expert Committee, and Associate Professor at the University of Sharjah.

A prolific scholar and mentor, Prof. Al Mazrouei has authored more than 60 peer-reviewed publications and is a passionate advocate for women in science and the global pharmacy workforce.

Dr. Ali Hassan is a Consultant Neurologist and Chief of the Neurology Division at STMC and Tawam Hospitals in Al Ain, UAE. He completed his MD in neurology from Al Azhar University, with specialized training in epilepsy and EEG from Case Western Reserve University, USA. He led the development of accredited stroke centers and founded key neurology conferences in the region. With over 40 publications, he is active in international research and guideline development. Dr. Hassan also trains neurologists in botox therapy and has received awards for teaching and quality leadership.

Prof. Bassam Ali received his PhD degree in Biochemistry from the University of Cambridge then worked at UCL and Imperial College London before joining UAEU in 2006.  He published over 190 original articles and reviews in international journals. His current research interests include: (1) Elucidation of the cellular and molecular mechanisms underlying human monogenic diseases and (2) pharmacogenomics and (3) precision medicine.

He has been awarded the 2018 Khalifa Education Award as the Distinguished University professor and the 2019 Shoman Award for Arab Scientists in Health Sciences as well as many awards from UAEU.  He supervised many postgraduate and medical research students and received numerous research grants. He is recognized internationally and is on the editorial boards of several leading international scientific journals including being Deputy Editor-in-Chief for “Human Genomics” and Associate Editor for The Pharmacogenomics Journal, the Journal of Translational Medicine, “Frontiers in Genetics” and “Frontiers in Pediatrics”. He is an expert on the topic of this proposal with numerous publications.

Dr. Sherif Kamal is a Senior Clinical Pharmacy Consultant with over 20 years of experience in oncology and clinical pharmacy practice. He currently serves as Advisor to the Chairman of the Egyptian Hospital Association (EHA) Board for Medication Management and Pharmacy Affairs and Vice President of the European Society of Oncology Pharmacy (ESOP) Global for all non-European countries.

Dr. Kamal earned his BSc and MSc in Pharmacy from Cairo University and is a PhD candidate at the same institution. He completed a fellowship at St. Jude Children’s Research Hospital, USA, and holds certifications in professional training, healthcare management, and Lean Six Sigma.

He founded the Egyptian Association of Clinical Pharmacists, led the implementation of clinical pharmacy services in major hospitals across Egypt, and directs regional initiatives to advance pharmacy practice across Africa. His research interests include pharmacogenetics, pharmacoeconomics, patient safety, and pediatric oncology.

Dr. Lina Wahba is the Head of Clinical Pharmacy Services and a Senior Oncology Clinical Pharmacist at the Adult Oncology Unit, Tawam Hospital, UAE. She also serves as an Adjunct Assistant Professor at the Faculty of Medicine and Health Sciences, United Arab Emirates University, and as the SEHA Residency Program Site Director at Tawam Hospital.

She earned her Bachelor of Science in Pharmacy from the Faculty of Pharmacy at Jordan University of Science and Technology, Jordan, followed by a Master’s degree in Clinical Pharmacy from University College London (UCL) School of Pharmacy, UK.

Dr. Wahba is a Board-Certified Oncology Pharmacist who maintains a primary clinical practice in the Tawam Oncology Unit. She leads the SEHA Pharmacy Clinical Council and the Tawam Medication Use Evaluation Committees, playing a pivotal role in optimizing patient care and developing, updating, and implementing oncology treatment protocols.

Her research contributions include numerous publications and abstracts presented at prestigious scientific meetings, including the UK Clinical Pharmacy Association Conference, the American Society of Health-System Pharmacists (ASHP) Midyear Meeting, the Emirates Oncology Conference, and in the Journal of Oncology Pharmacy Practice (JOPP).

In addition, Dr. Wahba serves as Principal Pharmacist for multiple Phase III multinational randomized clinical trials involving investigational chemotherapeutic and targeted agents.

Dr. Wadha Abdulrahman earned her Bachelor of Pharmacy degree from Fatima College of Health Sciences and began her career at Sheikh Khalifa Medical City (SKMC) as an outpatient pharmacist. She later completed the Clinical Pharmacy Residency Program and went on to serve as a clinical pharmacist for three years, covering Internal Medicine and the Pediatric Intensive Care Unit. During the COVID-19 pandemic, she played a vital role in the ICU, supporting physicians in drug therapy selection and medication management.

Dr. Wadha holds a Master’s degree in Social Sciences Research for Healthcare from the University of Bradford. In 2022, she joined the Department of Health (DOH) – Abu Dhabi, where she initially served as a Toxicology and Medication Education Specialist. She is currently a key member of the DOH Genome Team, contributing to the advancement of precision medicine initiatives, including premarital genetic testing, pharmacogenomics, and oncology flagship programs in Abu Dhabi.

Dr. Mohamed Nagy is a leading clinical pharmacogenomics expert and Pharmacy Director at Children's Cancer Hospital Egypt (CCHE) 57357, where he founded the Personalized Medication Management Unit. His research focuses on applying pharmacogenomics to optimize drug therapy in pediatric oncology.  

He is an active contributor to global pharmacogenomics advancements, Dr. Nagy co-authored Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and holds leadership roles in the African Pharmacogenomics Network and Pharmacogenomics Global Research Network (PGRN).  

Dr. Nagy has presented at international conferences and holds adjunct faculty positions, teaching pharmacogenomics and personalized medicine. He also mentors' residents through ASHP-accredited programs.  Dr. Nagy’s dedication to advancing personalized medicine and improving patient outcomes makes him a distinguished voice in clinical pharmacy and Clinical Pharmacogenomics. 

Dr. Zakarya Hussein Mohammad Harb is the Pharmacy Informatics & Automation Supervisor SEHA - Al Ain Region, UAE, bringing over 30 years of experience in pharmacy practice and 20 years in healthcare informatics and automation. 

He has led numerous large-scale digital transformation projects, including the implementation of Omnicell ADCs, Swisslog Autopharm Carousels, and Cerner EMR integration across major hospitals such as Tawam Hospital, Al Wagan Hospital, and Sheikh Tahnoon Medical City. Rowa Robotic pharmacy implementation at Tawam Polyclinic Pharmacy. 

He was recognized for participating in the development of the National Platform for Controlled Medication in collaboration with the Department of Health (DOH) and Ministry of Interior (MOI). A graduate of the Jordan University of Science and Technology, Zakarya combines clinical expertise with advanced informatics leadership to drive excellence in pharmacy practice. Pharmacy Benefit Management (PBM) implementation at Tawam hospital. 

Zakaria is a member of multiple committees at Al Ain region and SEHA 

A graduate of the Jordan University of Science and Technology, Zakarya combines clinical expertise with advanced informatics leadership to drive excellence in pharmacy practice

Dr. Khlood Catroon is a Senior Clinical Pharmacist at Corniche Hospital, the premier maternity hospital in Abu Dhabi. She earned both her B.Sc. (1990) and M.Sc. (1997) in Pharmacy from the College of Pharmacy, Baghdad University. Dr. Catroon is SIDP-certified and ASHP-certified in Emergency Medicine and Pharmacogenomics. She spent 12 years as an Assistant Teacher at the College of Pharmacy, Baghdad, before joining Corniche Hospital in 2008. At Corniche, Dr. Catroon has contributed extensively to research, quality improvement projects, audits, and medication safety initiatives at both the hospital and SEHA levels. She serves as Co-Chair of the Corniche Antimicrobial Stewardship Program (ASP) and Co-Chair of the hospital Pharmacy & Therapeutics Committee. Dr. Catroon has been recognized for her excellence in patient safety and quality improvement, including a Silver Award at the SEHA level for the QIP titled “A Collaborative Approach to Enhancing Medication Safety in a Tertiary Neonatal Intensive Care Unit”. She was also shortlisted for the IHSAN Award – 2021 3rd Cycle, the SEHA Allied Health Excellence Award, and the 1st and 2nd SEHA Audit Awards in 2024 and 2025 for Patient Safety. She actively participates in multiple committees at Corniche Hospital and SEHA, including leading ASP educational programs for SEHA staff. Dr. Catroon is a co-author of several published articles and has contributed as a scientific committee member and speaker at numerous national and international conferences.

Dr. El Mutasim Ahmed is a Senior Clinical Pharmacist with extensive experience in ICU practice, antimicrobial stewardship, and supervising clinical pharmacy services and pharmacy operations. He has been the Head of Pharmacy at Al Ain Hospital and currently leads the ICU clinical pharmacy services at STMC. He has served as chair and co- chair of several committees related to pharmacy practice and also an Adjunct Lecturer at the United Arab Emirates University, contributing to the training of pharmacy and Pharm D student. He is also actively involved in research and publications.  El Mutasim  holds a Master’s degree in Clinical Pharmacy from the United Kingdom, a Bachelor of Pharmacy (Honours) from the University of Khartoum, and a WHO certification in Antimicrobial Stewardship.

Dr. Mosa’b Al-Balas is an internationally accredited Clinical Pharmacist with leadership experience across Canadian and UAE healthcare systems. He serves at Sheikh Tahnoon Bin Mohammed Medical City (STMC) in Al Ain as a Clinical Pharmacist and Chair of the Pharmacy Research and Innovation Committee. A faculty member in SEHA’s ASHP-accredited Pharmacy Residency and Internal Medicine programs, Dr. Al-Balas is deeply involved in education, mentorship, and advancing clinical excellence. He previously held leadership roles in Canada, including Hospital Pharmacy Manager and Pharmacotherapy Specialist, earning recognition for excellence in patient-centered care. Holding a PharmD from the University of Toronto and an MBA from Wilfrid Laurier University, Dr. Al-Balas integrates clinical expertise, innovation, and quality improvement to elevate pharmacy practice and healthcare delivery.

Dr. Manal Rayyan is a distinguished Clinical Pharmacist specializing in pediatric oncology and hematology at Tawam Hospital, Al Ain. With over 18 years of experience across leading institutions in Jordan, Saudi Arabia, and the UAE, she has been instrumental in advancing oncology pharmacy practice and patient safety.

She holds a Master’s degree in Clinical Pharmacy from the University of Jordan and is board-certified in Pharmacotherapy (BCPS). She is also a Certified Proficient Oncology Pharmacist (HOPA) and a Certified European Oncology Pharmacist. As the UAE Delegate to the European Society of Oncology Pharmacy (ESOP), she actively contributes to global initiatives in oncology pharmacy education and policy.

Her leadership includes transforming chemotherapy prescribing from paper-based to a fully integrated Cerner electronic module across SEHA facilities, significantly enhancing safety and efficiency. She also leads the SEHA-wide WAVE project, focusing on clinical pharmacy documentation quality and cost-saving interventions.

In addition to her clinical role, Manal is a peer reviewer for the Journal of Pharmacy Practice and an adjunct lecturer at UAE University, mentoring PharmD and postgraduate students. Her research contributions span palliative care, pharmacoeconomics, and quality improvement, with multiple publications and international conference presentations.

Her commitment to excellence in clinical practice, education, and research continues to shape the future of oncology pharmacy in the region.

Dr. Sham ZainAlabdin is a Board-Certified Pharmacotherapy Specialist (BCPS) and Clinical Pharmacist with broad experience spanning academia, clinical practice, and research. Dr. Sham currently serves as a Lecturer and Clinical Instructor in the postgraduate PharmD program, Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University. where she coordinates clinical training rotations, hands-on understanding of both patient care and scientific inquiry, supervises student research and contributes to the development and quality assurance of experiential learning and preceptorship frameworks. 

Dr. Sham earned both her Bachelor of Pharmacy (BSc Pharm) and Master of Science in Clinical Pharmacy (MSc Clin Pharm) degrees from Ajman University, each with highest honors and distinction. Dr. Sham has authored or co-authored over 25 peer-reviewed publications in high impact factor international journals. Her research interests span pharmacotherapy optimization, pharmacovigilance of novel therapies such as biologics in dermatologic diseases, antimicrobial resistance, oncology supportive care, AI-supported clinical decision-making, and patient-centered outcomes.

Her dedication to advancing clinical education and research excellence has been recognized through numerous awards, including Best Oral and Poster Presentation Awards at SEHA Clinical Pharmacy Conferences, DUPHAT, and UAE University Research Day, Emirates Dermatology Society as well as an Innovation Award from the GDRFA AI Innovation Conference.

Dr. Mona Al Moussli is a leading figure in pharmaceutical and medical device regulatory affairs in the Middle East, with over 20 years of experience. She is the Co-Founder and Managing Director of PRA Consultancy, a firm recognized for driving regulatory excellence across the region

She has led major initiatives such as the GCC Regulatory Affairs Course, the GCC Pharma Regulatory Summit, and the AFRI Summit, shaping regulatory frameworks and building capacity across the Middle East and Africa

Dr. Mona also contributes to academia and community development through her advisory roles at Dubai Pharmacy College and the Dubai Chamber’s Women’s Business Council

Dr Fadi Alkhateeb, is a Senior Clinical Pharmacy Specialist with over 16 years of progressive experience in hospital and clinical pharmacy practice, specializing in Infectious Diseases, Antimicrobial Stewardship, and Critical Care. He currently serves as a Clinical Pharmacist (Infectious Diseases) and Antimicrobial Stewardship Co-Chair at Sheikh Tahnoon Medical City (STMC), United Arab Emirates, where he provides evidence-based pharmaceutical care and leads multidisciplinary stewardship initiatives.

Before joining STMC, Dr Alkhateeb held senior clinical pharmacy roles at the Armed Forces Hospital – Southern Region (AFHSR), Saudi Arabia, where he coordinated the Antimicrobial Stewardship Program, served as preceptor for PharmD interns and residents, and contributed to national AMS policy development under the Ministry of Defense.

Dr. Alkhateeb holds a Master of Science in Clinical Pharmacy from the University of Science Malaysia, and he is Board Certified in Pharmacotherapy (BCPS) and Infectious Diseases Pharmacy (BCIDP). His career is distinguished by active involvement in JCI and CBAHI accreditation surveys, quality improvement initiatives, and pharmacy education and leadership across major healthcare institutions in Saudi Arabia and the UAE.

Dr. Shorouq Telfah is a Clinical Pharmacist with over 15 years of experience at the King Hussein Cancer Center, where she supervise pharmacy practices and mentor residents. She hold a Doctor of Pharmacy (PharmD) and a Board-Certified Pharmacotherapy Specialist (BCPS).

She is currently pursuing a Master’s in Data Science and Artificial Intelligence at the University of Liverpool, combining her healthcare expertise with AI to enhance clinical decision-making and improve patient outcomes. She have developed and applied several machine learning models in healthcare, and she is actively involved in clinical research and publications. Her primary interest lies in integrating AI into healthcare to optimize clinical decisions and improve patient care.

Dr. Enas Bader is a highly experienced and dedicated Pharmacist with over the past 26 years of professional practice in hospital pharmacy operations across leading healthcare institutions in the UAE and Saudi Arabia. Currently serving at Sheikh Tahnoon Medical City (STMC) as inpatient pharmacy supervisor, she brings a strong track record in pharmacy excellence, regulatory compliance, and team leadership.

During her tenure at Tawam Hospital, Enas played a pivotal role as the Narcotic and Controlled Drugs Pharmacy In-Charge for five years, ensuring strict adherence to DOH and SEHA standards while promoting patient safety and operational efficiency. Her expertise spans drug management, policy development, and multidisciplinary collaboration to optimize pharmaceutical care.

She holds a Bachelor of Science in Pharmacy from Al Israa University, Jordan, and she received many recognition for her commitment to advancing pharmacy practice through innovation, integrity, and mentorship.

Dr. Azhar Talal Rahma is an Instructor at the Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University. She serves as the Coordinator of core courses for both MPH and PhD programs and Co-coordinator of the Public Health Clerkship, where she plays a central role in advancing graduate public health education and student mentorship.

Dr. Rahma is the Editor of the recently published Elsevier book Raising Genomic Literacy, Knowledge, and Awareness, and the Editor-in-Chief of the IPH Newsletter and editor of the Human Genomics Journal.

She holds several academic leadership roles, including Faculty Fellow at the Centre of Excellence in Teaching and Learning (CETL) at UAEU, Faculty Fellow of the Public Health Faculty through Distinction, UK, Adjunct Faculty at St. Thomas University (USA), and Global Public Health Mentor with the Global Health Mentoring (GHMe), Denmark.

She is also an active member of the ASPHER Task Force on Digital Public Health, contributing to the advancement of digital skills in public health curricula across Europe and the MENA region. Her researches had been published in Q1 journals and presented at international conferences.

Dr. Rahma won the Excellence in Teaching Award in recognition of her innovative teaching methods, integration of artificial intelligence (AI) tools into learning, and consistently outstanding evaluations from students. 

Prof. Heba Mohamed is a Professor at Faculty of Pharmacy, Cairo University-Egtpt with extensive experience in higher education, curriculum development, and quality assurance across the UAE and MENA region. She has held several academic leadership roles and contributed to national and international accreditation initiatives, as well as pharmacist capacity-building and upskilling programs. Recognized among the world’s top 2% scientists by Stanford and Elsevier, her work focuses on pharmaceutical sciences, bioanalysis, pharmacogenomics, and integrating artificial intelligence and digital health into pharmacy education and practice. She has led global collaboration and student mobility programs with leading universities to enhance experiential learning and international exposure for pharmacy students. Prof. Heba is an active member of the FIP Technology Advisory Group, the ISPOR-UAE Chapter Education and Training Committee, and a senior collaborator with the Global Burden of Disease (GBD) at IHME. She is passionate about preparing future-ready pharmacists through continuous development, ethical practice, and adaptability in digital healthcare.

Dr. Fatima Al Senaidi earned her Bachelor’s degree in Pharmacy from Fatima College of Health Sciences in 2016. She spent six years at Tawam Hospital’s Outpatient Pharmacy, gaining extensive experience in patient care and clinical operations.

She is a Board-Certified Pharmacist accredited by the American Society of Health-System Pharmacists (ASHP) in Infectious Diseases, Ambulatory Care, and Pharmacotherapy. She currently serves as a Clinical Pharmacist at Sheikh Tahnoon Medical City (STMC), where she specializes in Internal Medicine and Infectious Diseases, including HIV management.

Dr. Dina Al Jawamis earned her Doctor of Pharmacy (PharmD) degree from the University of Jordan in 2006. After two years of professional experience in Jordan, she relocated to the United Arab Emirates in 2008 and joined Tawam Hospital in Al Ain under SEHA Health Services, where she currently serves as a Senior Pharmacist.

She has an extensive experience in providing safe and effective Total Parenteral Nutrition (TPN) therapy for both pediatric and adult patients, including those with cancer. In 2021, she earned her Board Certification in Nutritional Support Pharmacy (BCNSP). She now leads the Parenteral Nutrition Services at Tawam Hospital and remains deeply committed to advancing clinical practice and education in nutrition support pharmacy.

Dr. Maram Odeh is a pharmacist with a Bachelor degree  in Pharmacy from  Applied Sciences University in Amman, Jordan (2001). She also holds an International Diploma in Business from Cambridge University.

She began her career with GlaxoSmithKline (GSK), where she worked in the marketing department. She later moved to the UAE , spending three years in community pharmacy practice before joining Tawam Hospital in 2015.

At Tawam Hospital, Dr. Maram serves as an inpatient pharmacist, contributing across multiple departments including the IV unit dose service, narcotics management, and inpatient care for both adult and pediatric patients. Her diverse experience combines strong clinical knowledge with business and communication skills, reflecting her commitment to advancing patient services 

Dr. Sheilla Rashid brings over 25 years of experience and leadership in the pharmacy profession. She currently serves with SEHA corporate hospitals (STMC/TW), providing expert critical care pharmacy services.

In addition to her clinical practice, Dr. Rashid is an Adjunct Lecturer and member of the Assessment and Quality Assurance Committee for the PharmD Program at UAE University. She has a strong track record in clinical teaching, actively mentoring pharmacy students and residents as a preceptor in the SEHA Pharmacy Residency Program.

Her dedication to academic excellence was recognized with the Best Faculty Award 2025. Dr. Rashid’s leadership philosophy centers on advancing patient care, fostering professional growth, and driving innovation in pharmacy practice across multidisciplinary teams.